Summary
- Current Price
- As of today, CRNX price is $35.57, down -0.70% on
- Current Price All-Time High
- CRNX price is currently -43.12% below its historical high of $62.53 set on
- Market Cap
- CRNX current market cap is $4B, up +14.15% over the past 365 days
- PE Ratio
- CRNX PE ratio is unknown
- Revenue
- CRNX current annual revenue is $7.70M, up +640.71% year-over-year
- Next Earnings
- The next earnings release for CRNX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Crinetics Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CRNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | crinetics.com |
| Employees | 437 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $35.57 | |
| Price, 1D Change | -0.70% | |
| $4B | ||
| - | ||
| - | ||
| 1.10 | ||
| $8M | ||
| Revenue, 1Y Change | +640.71% | |
| -$4.95 | ||
| EPS, 1Y Change | -33.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.95 | ||
| EPS Estimate | N/A | -$4.78 |
| EPS Est. Change | N/A | +3.42% |
| $7.70M | ||
| Revenue Estimate | N/A | $62.09M |
| Revenue Est. Change | N/A | +706.72% |
| Current Price | $35.57 | |
| Price Target | - | $88.00 |
| Price Tgt. Change | - | +147.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.71 | -$3.69 | +0.33% | |
| -$5.02 | -$4.95 | +1.53% | |
| -$4.78 | N/A | +3.42% | |
| -$4.08 | N/A | +17.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.60M | $1.04M | -35.25% | |
| $6.33M | $7.70M | +21.61% | |
| $62.09M | N/A | +706.72% | |
| $176.15M | N/A | +2,188.85% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $35.57 | |
| $39.68 | ||
| SMA 200 vs Price | +11.55% | |
| $45.69 | ||
| SMA 50 vs Price | +28.44% | |
| 1.10 | ||
| $1.84 | ||
| 26.37 | ||
| 32.44% | ||
| 58.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.70M | ||
| -$4.95 | ||
| $0.00 | ||
| 35.47% | ||
| -$516.77M | ||
| -6,714.77% | ||
| -$465.32M | ||
| -6,046.22% | ||
| -$512.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 12.32 | ||
| 12.30 | ||
| - | ||
| - | ||
| 14.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 473.80 | ||
| 3.68 | ||
| -5.20 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $992.08M | ||
| $1.03B | ||
| $1.14B | ||
| $1.05B | ||
| $143.41M | ||
| $85.07M | ||
| $48.54M | ||
| $6.49M | ||
| $22.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $473.01M | ||
| $519.50M | ||
| $4.97M | ||
| $191.33M | ||
| $3.89M | ||
| $0.00 | ||
| $180.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$377.92M | ||
| $173.91M | ||
| $40.61M | ||
| $5.76M | ||
| -$383.68M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | → | |
| Goldman Sachs | → | |
| Citizens | → | |
| Morgan Stanley | → | |
| Citizens | → | |
| Oppenheimer | → | |
| Morgan Stanley | → | |
| Leerink Partners | → | |
| JMP Securities | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with CRNX
FAQ
What is the ticker symbol for Crinetics Pharmaceuticals, Inc.?
The ticker symbol for Crinetics Pharmaceuticals, Inc. is NASDAQ:CRNX
Does Crinetics Pharmaceuticals, Inc. pay dividends?
No, Crinetics Pharmaceuticals, Inc. does not pay dividends
What sector is Crinetics Pharmaceuticals, Inc. in?
Crinetics Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Crinetics Pharmaceuticals, Inc. in?
Crinetics Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Crinetics Pharmaceuticals, Inc. based in?
Crinetics Pharmaceuticals, Inc. is headquartered in United States
When did Crinetics Pharmaceuticals, Inc. go public?
Crinetics Pharmaceuticals, Inc. initial public offering (IPO) was on July 18, 2018
Is Crinetics Pharmaceuticals, Inc. in the S&P 500?
No, Crinetics Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Crinetics Pharmaceuticals, Inc. in the NASDAQ 100?
No, Crinetics Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Crinetics Pharmaceuticals, Inc. in the Dow Jones?
No, Crinetics Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Crinetics Pharmaceuticals, Inc. last earnings report?
Crinetics Pharmaceuticals, Inc.'s most recent earnings report was on February 26, 2026
When does Crinetics Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Crinetics Pharmaceuticals, Inc. is May 7, 2026
Data Sources & References
- CRNX Official Website www.crinetics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1658247/000165824726000012/0001658247-26-000012-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658247/000165824726000012/0001658247-26-000012-index.htm
- CRNX Profile on Yahoo Finance finance.yahoo.com/quote/CRNX
- CRNX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crnx